IPO搁浅一年后，先正达据悉考虑最快明年香港上市

Group 1 - The core viewpoint is that Syngenta Group, a subsidiary of China National Chemical Corporation, is considering an IPO in Hong Kong after withdrawing its $9 billion domestic listing plan over a year ago [1][2] - Syngenta is reportedly in preliminary discussions with financial advisors and may list as early as next year [1] - The company plans to optimize its listing quality by potentially disposing of non-core and unprofitable assets during the Hong Kong IPO preparation [1] Group 2 - Syngenta, headquartered in Switzerland, was acquired by China National Chemical Corporation for $43 billion in 2017 [2] - The company initially submitted an IPO application to the Shanghai Stock Exchange in 2021, aiming to raise $9 billion, which would have been one of the largest IPOs in the Chinese market [2] - The IPO application was withdrawn in March 2024 due to market volatility, with the company indicating it would seek suitable opportunities for a listing in China or elsewhere [2] Group 3 - The Hong Kong IPO market is showing signs of recovery, with Bloomberg Industry Research estimating that the total fundraising amount for 2024 could exceed $40 billion, marking the highest level in four years [3] - Increased market activity is believed to provide a favorable window for large enterprises to go public [3]